表紙
市場調查報告書

臨床決策支援(CDS)的全球市場 - 產業分析,市場規模,佔有率,成長,趨勢,預測 2018年∼2025年

Global Clinical Decision Support Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025

出版商 Value Market Research 商品編碼 915945
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床決策支援(CDS)的全球市場 - 產業分析,市場規模,佔有率,成長,趨勢,預測 2018年∼2025年 Global Clinical Decision Support Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025
出版日期: 2019年10月01日內容資訊: 英文 100 Pages
簡介

本報告提供全球臨床決策支援(CDS)市場調查,市場概要,各產品、用途、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 報告的說明
  • 調查範圍
  • 調查方法

第2章 摘要整理

  • 市場概況
  • 市場概要

第3章 產業分析

  • 簡介
  • 市場成長要素
  • 市場阻礙因素
  • 市場機會
  • 市場趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主一覽
  • 行銷頻道

第5章 全球臨床決策支援決策(CDS)市場分析:各產品

  • 市場概要
  • 市場分析:各產品
  • 診斷用CDS
  • 治療用CDS

第6章 全球臨床決策支援決策(CDS)市場分析:各用途

  • 市場概要
  • 市場分析:各用途
  • 藥物過敏警告
  • 藥物相互作用
  • 臨床提醒
  • 臨床指南
  • 藥物給藥支援
  • 其他

第7章 全球臨床決策支援決策(CDS)市場分析:各地區

  • 市場概要:各地區
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 競爭情形

  • 市場競爭情形
  • 夥伴關係、合作、契約
  • 合併、收購
  • 新產品的銷售
  • 其他開發

第9章 企業簡介

  • ALLSCRIPTS
  • CERNER CORPORATION
  • ELSEVIER
  • EPIC SYSTEMS CORPORATION
  • KONINKLIJKE PHILIPS N.V.
  • MCKESSON CORPORATION
  • MEDICAL INFORMATION TECHNOLOGY, INC.
  • TRUVEN HEALTH ANALYTICS
  • WOLTERS KLUWER
  • ZYNX HEALTH
目錄

The report on global Clinical Decision Support market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2025. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

Drivers

  • Rising number of chronic diseases
  • Growing geriatric population

Restraints

  • Data security concerns
  • High investments

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Till: 2025

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

The report classifies the market into different segments based on product and application. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

The report also covers the complete competitive landscape of the worldwide market with company profiles of key players. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT:

By Product:

  • Diagnostic CDS
  • Therapeutics CDS

By Applications:

  • Drug Allergy Alert
  • Drug-Drug Interaction
  • Clinical Reminder
  • Clinical Guideline
  • Drug Dosing Support
  • Others

By Geography:

  • North America (NA) - US, Canada & Rest of North America
  • Europe (EU) - UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) - China, Japan, India & Rest of APAC
  • Latin America (LA) - Brazil & Rest of Latin America
  • Middle East & Africa (MEA) - Middle East and Africa

Table of Contents

1 PREFACE

  • 1.1. REPORT DESCRIPTION
    • 1.1.1. OBJECTIVE
    • 1.1.2. TARGET AUDIENCE
    • 1.1.3. UNIQUE SELLING PROPOSITION (USP) & OFFERINGS
  • 1.2. RESEARCH SCOPE
  • 1.3. RESEARCH METHODOLOGY
    • 1.3.1. MARKET RESEARCH PROCESS
    • 1.3.2. MARKET RESEARCH METHODOLOGY
      • 1.3.2.1. SECONDARY RESEARCH
      • 1.3.2.2. PRIMARY RESEARCH
      • 1.3.2.3. MODELS

2 EXECUTIVE SUMMARY

  • 2.1. MARKET HIGHLIGHTS
  • 2.2. GLOBAL CLINICAL DECISION SUPPORT MARKET SNAPSHOT

3 CLINICAL DECISION SUPPORT - INDUSTRY ANALYSIS

  • 3.1. INTRODUCTION
  • 3.2. MARKET DRIVERS
    • 3.2.1. DRIVER
    • 3.2.2. DRIVER
  • 3.3. MARKET RESTRAINTS
    • 3.3.1. RESTRAINT
    • 3.3.2. RESTRAINT
  • 3.4. OPPORTUNITIES
    • 3.4.1. OPPORTUNITY
  • 3.5. TRENDS
    • 3.5.1. TREND
    • 3.5.2. TREND
  • 3.6. PORTER'S FIVE FORCE ANALYSIS
  • 3.7. CLINICAL DECISION SUPPORT MARKET ATTRACTIVENESS ANALYSIS
    • 3.7.1. MARKET ATTRACTIVE ANALYSIS BY PRODUCT
    • 3.7.2. MARKET ATTRACTIVE ANALYSIS BY APPLICATION
    • 3.7.3. MARKET ATTRACTIVE ANALYSIS BY REGION

4 VALUE CHAIN ANALYSIS

  • 4.1. CLINICAL DECISION SUPPORT VALUE CHAIN ANALYSIS
  • 4.2. CLINICAL DECISION SUPPORT RAW MATERIAL ANALYSIS
    • 4.2.1. LIST OF RAW MATERIALS
    • 4.2.2. CLINICAL DECISION SUPPORT RAW MATERIAL MANUFACTURES LIST
    • 4.2.3. PRICE TREND OF CLINICAL DECISION SUPPORT KEY RAW MATERIALS
  • 4.3. LIST OF POTENTIAL BUYERS
  • 4.4. MARKETING CHANNEL
    • 4.4.1. DIRECT MARKETING
    • 4.4.2. INDIRECT MARKETING
    • 4.4.3. MARKETING CHANNEL DEVELOPMENT TREND

5 GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY PRODUCT

  • 5.1. OVERVIEW BY PRODUCT
  • 5.2. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY PRODUCT
  • 5.3. DIAGNOSTIC CDS
    • 5.3.1. OVERVIEW
  • 5.4. THERAPEUTICS CDS
    • 5.4.1. OVERVIEW

6 GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY APPLICATION

  • 6.1. OVERVIEW BY APPLICATION
  • 6.2. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY APPLICATION
  • 6.3. DRUG ALLERGY ALERT
    • 6.3.1. OVERVIEW
  • 6.4. DRUG-DRUG INTERACTION
    • 6.4.1. OVERVIEW
  • 6.5. CLINICAL REMINDER
    • 6.5.1. OVERVIEW
  • 6.6. CLINICAL GUIDELINE
    • 6.6.1. OVERVIEW
  • 6.7. DRUG DOSING SUPPORT
    • 6.7.1. OVERVIEW
  • 6.8. OTHERS
    • 6.8.1. OVERVIEW

7 GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. REGIONAL OUTLOOK
  • 7.2. INTRODUCTION
  • 7.3. NORTH AMERICA
    • 7.3.1. OVERVIEW
    • 7.3.2. NORTH AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY MARKET SEGMENT
    • 7.3.3. NORTH AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY
    • 7.3.4. UNITED STATE
    • 7.3.5. REST OF NORTH AMERICA
  • 7.4. EUROPE
    • 7.4.1. OVERVIEW
    • 7.4.2. EUROPE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY MARKET SEGMENT
    • 7.4.3. EUROPE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY
    • 7.4.4. UNITED KINGDOM
    • 7.4.5. FRANCE
    • 7.4.6. GERMANY
    • 7.4.7. REST OF EUROPE
  • 7.5. ASIA PACIFIC
    • 7.5.1. OVERVIEW
    • 7.5.2. ASIA PACIFIC CLINICAL DECISION SUPPORT MARKET ESTIMATE BY MARKET SEGMENT
    • 7.5.3. ASIA PACIFIC CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY
    • 7.5.4. CHINA
    • 7.5.5. JAPAN
    • 7.5.6. INDIA
    • 7.5.7. REST OF ASIA PACIFIC
  • 7.6. LATIN AMERICA
    • 7.6.1. OVERVIEW
    • 7.6.2. LATIN AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY MARKET SEGMENT
    • 7.6.3. LATIN AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY
    • 7.6.4. BRAZIL
    • 7.6.5. REST OF LATIN AMERICA
  • 7.7. MIDDLE EAST & AFRICA
    • 7.7.1. OVERVIEW
    • 7.7.2. MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY MARKET SEGMENT
    • 7.7.3. MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY
    • 7.7.4. MIDDLE EAST
    • 7.7.5. AFRICA

8 COMPETITIVE LANDSCAPE OF THE CLINICAL DECISION SUPPORT COMPANIES

  • 8.1. CLINICAL DECISION SUPPORT MARKET COMPETITION
  • 8.2. PARTNERSHIP/COLLABORATION/AGREEMENT
  • 8.3. MERGER AND ACQUISITIONS
  • 8.4. NEW PRODUCT LAUNCH
  • 8.5. OTHER DEVELOPMENTS

9 COMPANY PROFILES OF CLINICAL DECISION SUPPORT INDUSTRY

  • 9.1. ALLSCRIPTS
    • 9.1.1. COMPANY OVERVIEW
    • 9.1.2. FINANCIALS
    • 9.1.3. PRODUCTS
    • 9.1.4. RECENT DEVELOPMENTS
  • 9.2. CERNER CORPORATION
    • 9.2.1. COMPANY OVERVIEW
    • 9.2.2. FINANCIALS
    • 9.2.3. PRODUCTS
    • 9.2.4. RECENT DEVELOPMENTS
  • 9.3. ELSEVIER
    • 9.3.1. COMPANY OVERVIEW
    • 9.3.2. FINANCIALS
    • 9.3.3. PRODUCTS
    • 9.3.4. RECENT DEVELOPMENTS
  • 9.4. EPIC SYSTEMS CORPORATION
    • 9.4.1. COMPANY OVERVIEW
    • 9.4.2. FINANCIALS
    • 9.4.3. PRODUCTS
    • 9.4.4. RECENT DEVELOPMENTS
  • 9.5. KONINKLIJKE PHILIPS N.V.
    • 9.5.1. COMPANY OVERVIEW
    • 9.5.2. FINANCIALS
    • 9.5.3. PRODUCTS
    • 9.5.4. RECENT DEVELOPMENTS
  • 9.6. MCKESSON CORPORATION
    • 9.6.1. COMPANY OVERVIEW
    • 9.6.2. FINANCIALS
    • 9.6.3. PRODUCTS
    • 9.6.4. RECENT DEVELOPMENTS
  • 9.7. MEDICAL INFORMATION TECHNOLOGY, INC.
    • 9.7.1. COMPANY OVERVIEW
    • 9.7.2. FINANCIALS
    • 9.7.3. PRODUCTS
    • 9.7.4. RECENT DEVELOPMENTS
  • 9.8. TRUVEN HEALTH ANALYTICS
    • 9.8.1. COMPANY OVERVIEW
    • 9.8.2. FINANCIALS
    • 9.8.3. PRODUCTS
    • 9.8.4. RECENT DEVELOPMENTS
  • 9.9. WOLTERS KLUWER
    • 9.9.1. COMPANY OVERVIEW
    • 9.9.2. FINANCIALS
    • 9.9.3. PRODUCTS
    • 9.9.4. RECENT DEVELOPMENTS
  • 9.10. ZYNX HEALTH
    • 9.10.1. COMPANY OVERVIEW
    • 9.10.2. FINANCIALS
    • 9.10.3. PRODUCTS
    • 9.10.4. RECENT DEVELOPMENTS

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL DECISION SUPPORT MARKET SNAPSHO
  • TABLE 2. DRIVERS OF THE GLOBAL CLINICAL DECISION SUPPORT MARKET IMPACT ANALYSI
  • TABLE 3. RESTRAINTS OF THE GLOBAL CLINICAL DECISION SUPPORT MARKET IMPACT ANALYSI
  • TABLE 4. LIST OF RAW MATERIA
  • TABLE 5. LIST OF RAW MATERIAL MANUFACTURE
  • TABLE 6. LIST OF POTENTIAL BUYER
  • TABLE 7. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY PRODUCT (USD MN
  • TABLE 8. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN DIAGNOSTIC CDS BY GEOGRAPHY (USD MN
  • TABLE 9. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN THERAPEUTICS CDS BY GEOGRAPHY (USD MN
  • TABLE 10. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY APPLICATION (USD MN
  • TABLE 11. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN DRUG ALLERGY ALERT BY GEOGRAPHY (USD MN
  • TABLE 12. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN DRUG-DRUG INTERACTION BY GEOGRAPHY (USD MN
  • TABLE 13. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN CLINICAL REMINDER BY GEOGRAPHY (USD MN
  • TABLE 14. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN CLINICAL GUIDELINE BY GEOGRAPHY (USD MN
  • TABLE 15. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN DRUG DOSING SUPPORT BY GEOGRAPHY (USD MN
  • TABLE 16. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN OTHERS BY GEOGRAPHY (USD MN
  • TABLE 17. GLOBAL CLINICAL DECISION SUPPORT MARKET BY GEOGRAPHY (USD MN)
  • TABLE 18. NORTH AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 19. NORTH AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 20. NORTH AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY (USD MN)
  • TABLE 21. UNITED STATE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 22. UNITED STATE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 23. REST OF NORTH AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 24. REST OF NORTH AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 25. EUROPE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 26. EUROPE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 27. EUROPE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY (USD MN)
  • TABLE 28. UNITED KINGDOM CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 29. UNITED KINGDOM CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 30. FRANCE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 31. FRANCE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 32. GERMANY CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 33. GERMANY CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 34. REST OF EUROPE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 35. REST OF EUROPE CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 36. ASIA PACIFIC CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 37. ASIA PACIFIC CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 38. ASIA PACIFIC CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY (USD MN)
  • TABLE 39. CHINA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 40. CHINA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 41. JAPAN CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 42. JAPAN CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 43. INDIA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 44. INDIA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 45. REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 46. REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 47. LATIN AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 48. LATIN AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 49. LATIN AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY (USD MN)
  • TABLE 50. BRAZIL CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 51. BRAZIL CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 52. REST OF LATIN AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 53. REST OF LATIN AMERICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 54. MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 55. MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 56. MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY COUNTRY (USD MN)
  • TABLE 57. MIDDLE EAST CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 58. MIDDLE EAST CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 59. AFRICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY PRODUCT (USD MN)
  • TABLE 60. AFRICA CLINICAL DECISION SUPPORT MARKET ESTIMATE BY APPLICATION (USD MN)
  • TABLE 61. PARTNERSHIP/COLLABORATION/AGREEMENT
  • TABLE 62. MERGERS AND ACQUISITON
  • TABLE 63. NEW PRODUCT LAUNCH
  • TABLE 64. OTHER DEVELOPMENTS
  • TABLE 65. COMPANY MARKET SHARE ANALYSIS, 2018
  • TABLE 66. FINANCIAL HIGHLIGHTS
  • TABLE 67. MAJOR PRODUCTS
  • TABLE 68. FINANCIAL HIGHLIGHTS
  • TABLE 69. MAJOR PRODUCTS
  • TABLE 70. FINANCIAL HIGHLIGHTS
  • TABLE 71. MAJOR PRODUCTS
  • TABLE 72. FINANCIAL HIGHLIGHTS
  • TABLE 73. MAJOR PRODUCTS
  • TABLE 74. FINANCIAL HIGHLIGHTS
  • TABLE 75. MAJOR PRODUCTS
  • TABLE 76. FINANCIAL HIGHLIGHTS
  • TABLE 77. MAJOR PRODUCTS
  • TABLE 78. FINANCIAL HIGHLIGHTS
  • TABLE 79. MAJOR PRODUCTS
  • TABLE 80. FINANCIAL HIGHLIGHTS
  • TABLE 81. MAJOR PRODUCTS
  • TABLE 82. FINANCIAL HIGHLIGHTS
  • TABLE 83. MAJOR PRODUCTS
  • TABLE 84. FINANCIAL HIGHLIGHTS
  • TABLE 85. MAJOR PRODUCTS

LIST OF FIGURES

  • FIG. 1. RESEARCH SCOPE OF CLINICAL DECISION SUPPORT REPORT
  • FIG. 1. MARKET RESEARCH PROCESS
  • FIG. 2. MARKET RESEARCH METHODOLOGY
  • FIG. 3. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY REGION (USD MN)
  • FIG. 4. PORTERS FIVE FORCES ANALYSIS
  • FIG. 5. MARKET ATTRACTIVENESS ANALYSIS BY PRODUCT
  • FIG. 6. MARKET ATTRACTIVENESS ANALYSIS BY APPLICATION
  • FIG. 7. MARKET ATTRACTIVENESS ANALYSIS BY REGION
  • FIG. 8. VALUE CHAIN ANALYSIS
  • FIG. 9. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY PRODUCT (USD MN)
  • FIG. 10. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN DIAGNOSTIC CDS BY REGION
  • FIG. 11. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN THERAPEUTICS CDS BY REGION
  • FIG. 12. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS BY APPLICATION (USD MN)
  • FIG. 13. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN DRUG ALLERGY ALERT BY REGION
  • FIG. 14. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN DRUG-DRUG INTERACTION BY REGION
  • FIG. 15. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN CLINICAL REMINDER BY REGION
  • FIG. 16. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN CLINICAL GUIDELINE BY REGION
  • FIG. 17. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN DRUG DOSING SUPPORT BY REGION
  • FIG. 18. GLOBAL CLINICAL DECISION SUPPORT MARKET ANALYSIS IN OTHERS BY REGION
  • FIG. 19. GLOBAL CLINICAL DECISION SUPPORT MARKET BY REVENUE
  • FIG. 20. NORTH AMERICA CLINICAL DECISION SUPPORT MARKET BY REVENUE
  • FIG. 21. EUROPE CLINICAL DECISION SUPPORT MARKET BY REVENUE
  • FIG. 22. ASIA PACIFIC CLINICAL DECISION SUPPORT MARKET BY REVENUE
  • FIG. 23. LATIN AMERICA CLINICAL DECISION SUPPORT MARKET BY VOLUME & REVENUE
  • FIG. 24. MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT MARKET BY REVENUE
  • FIG. 25. RECENT DEVELOPMENT IN CLINICAL DECISION SUPPORT INDUSTRY
  • FIG. 26. COMPANY MARKET SHARE ANALYSIS, 2018
Back to Top